MyMD Pharmaceuticals Inc
Biotechnology
Healthcare
MYMD
39.79 M shares
NASDAQ US
traded
14 Aug 2023
listed
yes
open
1.33
52 week high
5.80
high
1.37
52 week low
1.32
low
1.29
growth
-62.11 %
previous Close
1.44
P/E ratio
market cap
64.95 M
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
-433.15 K
88.24 %
eps
0.00 %
55.74 %
eps surprise
0.00 %
net profit margin
-43314500.00 %
0.00 %
operating incoming
-2.59 M
31.98 %
net change in cash
-560.54 K
-227.64 %
cash on hand
189 K
-74.83 %
cost of revenue
0.00 %
top top